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Objectives The goal of this study was to examine the progression of central arterial pulse pressure (cPP) in women and the
degree to which this can be reversed by nitrovasodilation.
Background cPP can be partitioned into height of the first systolic shoulder (P1), generated by a forward pressure wave and
related to arterial stiffness, and augmentation pressure (AP), thought to be influenced by pressure wave reflec-
tion from muscular arteries and/or aortic reservoir.
Methods Using a longitudinal cohort design, cPP, P1, and AP were estimated (using the SphygmoCor System [AtCor Medi-
cal Pty Ltd., West Ryde, Australia]) in 411 female twins over a mean follow-up of 10.8 years. In a subsample
(n  42), cPP, arterial stiffness (using pulse wave velocity [PWV]) and arterial diameters (using ultrasonography)
were measured before and after nitroglycerin administration (400 g s/l).
Results cPP increased more than peripheral pulse pressure (10.3 and 9.2 mm Hg, respectively; p  0.0001). In women
60 years of age at follow-up, AP contributed more to the increase in cPP than did P1 (increases of 6.5  6.4
mm Hg and 4.2  7.8 mm Hg, respectively). P1 was significantly positively correlated to PWV (p  0.0001); AP
was correlated to aorto-femoral tapering (p  0.0001) but not PWV. Nitroglycerin reduced cPP by 10.0  6.0
mm Hg (p  0.0001), equivalent to a decade of aging. The reduction in cPP was entirely explained by a de-
crease in AP, with no significant change in P1 or PWV but an increase in large artery diameters of 4% to 18%
(p  0.0001).
Conclusions Age-related widening of cPP is driven in large part by an increase in AP, which can be reversed by selective dila-
tion of muscular arteries, independent of PWV. (J Am Coll Cardiol 2012;59:475–83) © 2012 by the American
College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.10.871Pulse pressure (PP), a major risk factor for cardiovascular
disease events (1–4), has traditionally been thought to be
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2011, accepted October 4, 2011.determined by stiffness of the aorta, with age-related aortic
stiffening leading to an irreversible increase in PP (5).
Central pulse pressure (cPP), more closely related to car-
diovascular (CVD) events than peripheral pulse pressure
(pPP) in most prospective studies (6–8), can be partitioned
into the height of the first shoulder of the central pulse wave
(P1) and augmentation pressure (AP) (Fig. 1). P1 is
determined by interaction of left ventricular ejection with
the impedance of the circulation and is related to aortic
stiffness. AP is thought to be determined by pressure wave
reflection from the periphery of the circulation (9) and/or by
the functional compliance or “reservoir function” of the
aorta (10,11). Compared with P1, AP bears little or no
relation to aortic stiffness and can be influenced by nitrova-
sodilation independent of any effect on aortic stiffness or
peripheral resistance (12,13). The relative contributions of
P1 and AP to the age-related increase in PP and the degree
to which this can be reversed are unknown. The aim of the
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Progression of Central Pulse Pressure January 31, 2012:475–83present study was to determine
the pattern of change in cPP over
time in women during a 10-year
follow-up. We examined the
contribution of P1 and AP to the
age-related increase in cPP and
the degree to which the contri-
bution of AP to cPP can be
reversed by nitroglycerin (NTG),
a drug known to have selective
effects on AP (14,15).
Methods
Study population. Subjects
comprised 423 unselected female
white twins who had central blood
pressure measurements performed
between 1996 and 2001 (age 48 
9 years), and approximately 11
years later between 2006 and
2010, as part of the Twins UK
rogramme of research. Of the 423 women, 12 had incom-
lete data on central pressure measurements and were
xcluded from the final analysis, leaving a final number of
11 women (49 monozygotic and 156 dizygotic pairs). The
tudy was approved by the research ethics committee of St.
homas’ Hospital, and written informed consent was obtained
rom all subjects.
nthropometric and clinical characteristics and labora-
ory measures. At baseline and follow-up, height and
eight were measured, and smoking status, menopausal
tatus, and medication use were recorded. Fasting total
holesterol, high-density lipoprotein cholesterol, triglycer-
des, glucose, and creatinine (at baseline only) were mea-
ured in an accredited laboratory.
emodynamic and ultrasound measurements. Central
lood pressure measurements were estimated by applying a
Abbreviations
and Acronyms
AIx  augmentation index
AP  augmentation
pressure
CI  confidence interval
cPP  central pulse
pressure
CVD  cardiovascular
disease
MAP  mean arterial
pressure
NTG  nitroglycerin
P1  pressure of the first
systolic shoulder
PP  pulse pressure
pPP  peripheral pulse
pressure
PWV  pulse wave velocity
Figure 1 Peripheral and Aortic Pressure Waveforms
Peripheral (radial) and central (aortic) pressure waveforms. AP  augmentation pre
DBP  diastolic blood pressure; P1  pressure of the incident wave; pPP  peripeneralized transfer function incorporated within the
phygmoCor system (AtCor Medical Pty Ltd., West Ryde,
ustralia) to radial artery pressure waveforms as described
reviously (12). Briefly, the radial pulse waveform was
ecorded by using applanation tonometry with a high-
delity transducer (Millar Instruments, Inc., Houston,
exas) and calibrated to supine brachial blood pressure
sing a validated oscillometric device (Omron HEM713C
t baseline and Omron 705CP at follow-up; Omron Cor-
oration, Tokyo, Japan). Mean arterial pressure (MAP) was
erived by integration of the radial artery waveform. cPP,
1, and AP were determined from the synthesized aortic
ressure waveforms (Fig. 1). Augmentation index (AIx) was
alculated as: AP/cPP  100%. PP amplification ratio was
alculated as pPP/cPP. As a check on the validity of the
ransfer function to assess the contributions of P1 and AP to
PP, P1 and AP were additionally estimated from carotid
onometry in a subsample of women from the follow-up
tudy and other women of similar age from the Twins UK
ohort (total, n  411). Only high-quality carotid wave-
orms were included (known to approximate aortic wave-
orms [16]), defined using quality-control criteria in the
phygmoCor System and by visual inspection by an ob-
erver blinded to radial tonometry results. Carotid wave-
orms were calibrated to MAP and diastolic blood pressure.
or comparison with central blood pressure derived using
he transfer function, carotid waveforms were calibrated to
ive the same cPP as obtained by the transfer function.
Carotid-femoral PWV and diameter of the abdominal
orta and femoral arteries were measured at follow-up.
WV was calculated from sequential recordings of carotid
nd femoral artery pressure waveforms using the same
phygmoCor device and transducer. Difference in time of
ulse arrival from the R-wave of the electrocardiogram be-
ween the 2 sites was taken as the transit time, and difference
n path length was estimated using surface measurements as
reviously described (12). Measurements were made in tripli-
; cPP  central pulse pressure; cSBP  central systolic blood pressure;
ulse pressure; pSBP  peripheral systolic blood pressure.ssure
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January 31, 2012:475–83 Progression of Central Pulse Pressurecate, and mean values were used for analysis. Diameters of the
abdominal aorta and femoral arteries were obtained using a
Siemens CV70 ultrasound system (CV 70, Acuson-Siemens
Corp., Mountain View, California). Abdominal aortic diam-
eter was determined by scanning the epigastrium vertically at
the xiphoid process; measurements were made 1 to 2 cm below
the diaphragm at end-diastole with a 4-MHz transducer. Left
and right femoral artery diameter was recorded 1 cm proximal
to the femoral bifurcation using a 13-MHz vascular probe.
Diameters were then measured offline using automated wall
tracking software (Medical Imaging Applications, Coralville,
Iowa) at end-diastole.
NTG study. The NTG study was performed in a sub-
sample of 42 women (mean age 57.5  9.4 years) at
follow-up. Exclusion criteria included nitrate therapy,
known hypersensitivity to nitrates, and hypotension (100
mm Hg systolic blood pressure and/or 60 mm Hg
diastolic blood pressure). After a minimum of 10 min
supine, baseline measurements of blood pressure, synthe-
sized aortic pressure waveforms, PWV, and aortic and
femoral diameters were determined as described here earlier.
Additional measurements of left carotid and brachial diam-
eter were conducted using the 13-MHz vascular probe at
end-diastole. Measurements were repeated 3 to 15 min after
sublingual administration of 400 g of NTG during which
ime the vascular response to NTG remains stable.
tatistical analysis. Data analysis was performed using
PSS version 16.0 (SPSS Inc., Chicago, Illinois). Subject
haracteristics are presented as mean SD unless otherwise
tated. Comparisons between measures at baseline and
ollow-up were made using the Student paired t test,
ilcoxon signed rank test, and McNemar test. Analysis was
epeated in women 50 years of age and 50 years of age
ecause the prognostic importance of cPP changes between
0 and 60 years and the median age at baseline was
pproximately 50 years. Differences in progression between
omen age 50 years and 50 years and comparison of
rogression of P1 and AP between age groups was by
nalysis of variance. Annual progression of cPP, P1, AP,
nd AIx was taken as the difference between follow-up and
aseline measurements divided by the time between visits in
ears. Potential determinants of central blood pressure
omponents at follow-up were examined using forward
ultivariable regression models with central blood pressure
omponents as dependent variables. Variables significantly
ssociated with the dependent variable on univariate analysis
r previously shown to be associated with this variable were
ncluded as independent variables. All regression models
ere further adjusted for menopausal status and antihyper-
ensive and hormone replacement therapy.
Genetic influences on cPP, P1, and AP progression were
mplicated by a higher intraclass correlation between genet-
cally identical monozygotic twins compared with dizygotic
wins, who share approximately 50% of their genes. To
etermine the proportion of phenotypic variation attribut-
ble to additive (A) genetic factors, common environment iC), and unique environment (E; incorporating measure-
ent error), structural equation model-fitting analysis was
erformed using Mx software (University of Virginia, Char-
ottesville, Virginia). ACE parameters and their corre-
ponding confidence intervals (CIs) were estimated using
he method of maximum likelihood. The overall goodness-
f-fit of the ACE model was compared against the saturated
odel (which perfectly describes the data without any
ssumptions) using likelihood ratio tests. The significance of
ach of the ACE parameters was tested by setting it to zero
nd testing the fit of the submodel to the full model. Twin
ata were adjusted for baseline age, hypertension treatment
t baseline and follow-up, change in MAP, and heart rate
sing regression procedures.
esults
ubject characteristics at baseline and follow-up are shown
n Table 1. The mean duration of follow-up was 10.8  1.2
years. Compared with visit 1, weight, total cholesterol,
high-density lipoprotein cholesterol, and fasting glucose
increased, whereas height, heart rate, and smoking fre-
quency decreased. The number of women receiving treat-
ment for hypertension and hyperlipidemia increased from
6% to 13% and from 1% to 13%, respectively.
Progression of peripheral and central blood pressure.
Over the follow-up period, peripheral and central systolic
blood pressure increased, whereas diastolic blood pressure
decreased (each p  0.0001) (Table 1). Consequently, PP
increased, with cPP increasing more compared with pPP
(mean increases of 10.3 12.9 mm Hg and 9.2 11.5 mm
Hg, respectively; p  0.0001), and PP amplification ratio
was reduced (p  0.0001). The greater increase in cPP
compared with pPP was driven mainly by women age 50
years at baseline (cPP 9.1  10.5 mm Hg; pPP 7.6 
2.3 mm Hg [p  0.0001]) compared with those age
50 years (cPP 12.1  12.6 mm Hg; pPP 11.5 
3.5 mm Hg [p  NS]). Reduction in PP amplification
atio was higher in women age 50 years compared with
hose age 50 years at baseline (change in amplification
atio – 0.12  0.21 and –0.08  0.13, respectively; p 
0.01). In women who remained untreated for hypertension,
cPP increased by 9.6 10.6 mm Hg and pPP by 8.3 12.3
mm Hg (p  0.0001). MAP remained similar at baseline
and follow-up.
Progression of P1 and AP. In the total cohort, P1 in-
creased by 4.2 7.8 mmHg (17.0%; p 0.0001) (Table 1),
whereas AP increased by 6.5  6.4 mm Hg (82.3%) over
the follow-up period. In women who remained untreated
for hypertension, P1 increased by 3.5 7.4 mm Hg (14.3%;
p  0.0001) and AP increased by 6.4  7.4 mm Hg
87.7%). Annual progression of AP was significantly greater
han that of P1 in women age 50 years at baseline.
owever, after 50 years of age, progression of AP and P1
ecame comparable (Fig. 2). This finding was due to a
ncrease in P1 progression after 50 years of age (p  0.01),
astolic
ulder; P
478 Cecelja et al. JACC Vol. 59, No. 5, 2012
Progression of Central Pulse Pressure January 31, 2012:475–83whereas progression of AP was comparable across age
categories. Annual progression of AIx decreased with older
age (p  0.0001) (Fig. 3).
Relation of P1, AP, AIx, and cPP to PWV and arterial
diameters at follow-up visit. The relation of P1, AP, AIx,
and cPP to PWV and arterial diameters in regression
models also incorporating other factors known to influence
Subject Characteristics at Baseline and Follow-Table 1 Subject Characteristics at Baseline
Characteristic
Baseline
(n  411)
Age (yrs) 47.6 9.4
Height (cm) 161.8 6.0
Weight (kg) 66.0 11.5
Heart rate (beats/min) 72.6 11.1
Peripheral SBP (mm Hg) 118.9 15.8
Peripheral DBP (mm Hg) 76.1 11.1
MAP (mm Hg) 92.4 13.1
Central SBP (mm Hg) 110.3 16.0
Central DBP (mm Hg) 77.4 11.3
P1 (mm Hg) 24.7 6.2
AP (mm Hg) 7.9 5.8
AIx (%) 22.4 14.9
PP amplification ratio 1.33 0.17
Total cholesterol (mmol/l) 5.5 1.1
HDL cholesterol (mmol/l) 1.5 0.4
Glucose (mmol/l) 4.6 (4.27–4.97
Triglycerides (mmol/l) 1.0 (0.75–1.37
Creatinine (mol/l) 74.4 9.8
Current smoker 70 (17)
Hypertension treatment 25 (6)
Lipid-lowering treatment 3 (1)
Diabetes mellitus 2 (1)
Values are mean  SD, median (interquartile range), or n (%). *Mean
AP  augmentation pressure; AIx  augmentation index; DBP  di
pressure; NS  not significant; P1  pressure of the first systolic sho
Figure 2 Central Pulse Pressure
Mean values of cPP separated into pressure of the forward wave (P1) and AP
at baseline and follow-up in women 50 and 50 years of age at baseline.
Abbreviations as in Figure 1.these measures (age, height, and heart rate) is shown in
Table 2. Because AP may be influenced by magnitude of the
outgoing wave, P1 was included as a potential explanatory
Follow-Up
Follow-up*
(n  411) p Value
58.2 9.0 0.0001
161.4 6.0 0.0001
69.8 12.5 0.0001
63.6 9.5 0.0001
125.0 15.9 0.0001
73.0 8.3 0.0001
92.3 10.6 NS
117.1 15.7 0.0001
73.9 8.3 0.0001
28.8 6.5 0.0001
14.4 6.5 0.0001
32.3 8.2 0.0001
1.22 0.14 0.0001
5.6 1.0 0.05
1.8 0.5 0.0001
5 (4.7–5.3) 0.0001
0.98 (0.72–1.31) NS
— —
43 (10) 0.0001
54 (13) 0.0001
54 (13) 0.0001
6 (1) NS
n of follow-up was 10.8 years.
blood pressure; HDL  high-density lipoprotein; MAP  mean arterial
P  pulse pressure; SBP  systolic blood pressure.
Figure 3 Annual Progression of P1, AP, and AIx According to Age
Mean annual progression of AP, P1, and augmentation index (AIx) according to
baseline age categories. AP progression was significantly greater than P1 in
women aged 50 years, after which progression of P1 and AP was compara-
ble. n  100, 71, 100, and 140 for age groups 40 years, 41 to 45 years, 46 to
50 years, and 50 years, respectively. Abbreviations as in Figure 1.Upand
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January 31, 2012:475–83 Progression of Central Pulse Pressurevariable for AP. P1 was significantly correlated with PWV.
In younger patients and in the total cohort, AP was
negatively correlated with femoral/aortic diameter but was
not independently correlated with PWV. AIx was also
negatively correlated with femoral/aortic and weakly nega-
tively correlated with PWV. Compared with P1, cPP was
less strongly correlated to PWV and was negatively corre-
lated to femoral/aortic diameter in younger women and in
the total cohort. Results were similar when analyzing P1
and AP obtained from carotid waveforms.
Effects of NTG on AP and P1. The age (57.5 9.4 years)
and blood pressures of women participating in the NTG
study were similar to those of the whole cohort at follow-up
(Fig. 4A). NTG had a moderate effect on diastolic blood
pressure (reduction from 74.1  7.6 mm Hg to 70.3  7.1
mm Hg; p  0.0001) but reduced central systolic blood
pressure from 117.2  13.9 mm Hg to 103.4  12.8 mm
Hg (p  0.0001) and cPP from 43.1  10.0 mm Hg to
33.1  8.3 mm Hg (p  0.0001). PP amplification ratio
Relation of P1, AP, AIx, and cPP to PWV, Femoral/Aortic DiameteAccording to Multivariable Regression AnalysisTable 2 Relation of P1, AP, AIx, and cPP t PWV, Femoral/AoAccording to Multivariable Regression Analysis
Variable
Age <50 yrs
Incremental
 R2 p Value
Dependent variable: P1
PWV 0.25 0.03 0.0001
MAP 0.43 0.27 0.0001
HR 0.16 0.02 0.01
DFA — — —
Age
Height — — —
Dependent variable: AP
PWV — — —
P1 — — —
MAP 0.54 0.24 0.0001
HR 0.47 0.15 0.0001
DFA 0.21 0.05 0.0001
Age 0.24 0.08 0.0001
Height 0.11 0.01 0.05
Dependent variable: AIx
PWV 0.13 0.01 0.05
MAP 0.48 0.12 0.0001
HR 0.42 0.14 0.0001
DFA 0.26 0.09 0.0001
Age 0.27 0.05 0.0001
Height 0.18 0.03 0.05
Dependent variable: cPP
PWV 0.15 0.01 0.01
MAP 0.6 0.38 0.0001
HR 0.39 0.08 0.0001
DFA 0.15 0.02 0.01
Age 0.15 0.04 0.01
Height — — —
All analysis is adjusted for menopausal status and antihypertensive and hormone replacement th
DFA  ratio of femoral to abdominal aortic diameter;   standardized regression coefficient;increased from 1.19  0.13 to 1.43  0.17 (p  0.0001). wThe decrease in cPP was entirely explained by a decrease in
AP (from 15.2  6.3 mm Hg to 5.9  4.3 mm Hg; p 
0.0001) with no significant change in P1. There was no
significant change in PWV. Abdominal, femoral, carotid,
and brachial artery diameters increased by 3.7%, 4.6%,
5.6%, and 18.1%, respectively (each p  0.0001) (Fig. 4B).
here was a small increase in heart rate from 60.7  8.3
eats/min to 62.0  8.4 beats/min (p  0.05).
omparison of P1 and AP determined by radial and
arotid tonometry. P1 was higher when measured at the
arotid artery compared with the transformed radial mea-
urements (33.7  7.3 mm Hg vs. 27.5  6.0 mm Hg; p 
.0001) (Fig. 5) and AP lower (11.4  7.3 mm Hg vs. 13 
.7 mm Hg; p  0.0001), consistent with previous obser-
ations (16). However, values of P1 and AP obtained by
sing the 2 methods were highly correlated (R  0.81 and
.83 for P1 and AP, respectively; each p  0.0001) and the
elative contributions of P1 and AP to cPP across the
istribution of cPP showed a similar trend irrespective of
Other Factors at Follow-Upiameter, and Other Factors at Follow-Up
Age >50 yrs Total Cohort
Incremental Incremental
R2 p Value  R2 p Value
0.13 0.0001 0.33 0.32 0.0001
0.34 0.0001 0.39 0.10 0.0001
0.06 0.0001 0.18 0.04 0.0001
— — — — —
0.05 0.0001 0.18 0.03 0.0001
— — — — —
— — — — —
0.36 0.0001 0.12 0.27 0.01
0.11 0.0001 0.47 0.12 0.0001
0.15 0.0001 0.45 0.10 0.0001
— — 0.16 0.02 0.0001
0.01 0.05 0.31 0.10 0.0001
— — 0.07 0.01 0.05
— — 0.12 0.01 0.05
0.07 0.0001 0.39 0.13 0.0001
0.32 0.0001 0.46 0.14 0.0001
0.02 0.01 0.21 0.04 0.0001
— — 0.27 0.07 0.0001
0.04 0.0001 0.14 0.02 0.0001
0.03 0.0001 0.21 0.03 0.0001
0.39 0.0001 0.53 0.35 0.0001
0.17 0.0001 0.45 0.12 0.0001
— — 0.07 0.01 0.05
0.11 0.0001 0.32 0.17 0.0001
— — — — —
eart rate; PWV  pulse wave velocity; other abbreviations as in Table 1.r, andtic D

0.29
0.48
0.22
—
0.27
—
—
0.24
0.46
0.51
—
0.19
—
—
0.30
0.67
0.16
—
0.20
0.20
0.59
0.43
—
0.26
—hether they were determined from the carotid or trans-
w
d
r
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Progression of Central Pulse Pressure January 31, 2012:475–83formed radial waveforms. Thus, when comparing the mean
difference in cPP in subjects with carotid cPP 40 mm Hg
and 50 mm Hg, AP accounted for 55% and 57% of this
difference when measured from the transformed radial and
carotid waveforms, respectively.
Heritability analysis of progression of cPP, P1, and
AP. Intraclass correlations for cPP, P1, and AP progression
ere higher for monozygotic twin pairs compared with
izygotic twin pairs, suggesting a genetic influence. The
esults of the model fitting are shown in Table 3. The
best-fitting model for cPP, P1, and AP progression was
the AE submodel, from which the heritability estimates
Figure 4 Central Pulse Pressure and Diameter Change After NT
(A) P1 and AP at baseline and follow-up (after 10.8 years) in total cohort and afte
AP reduction after NTG reverses approximately a decade of aging. (B) Diameter ch
Figure 5 Central and Carotid Pulse Pressure
Comparison of P1 and AP derived from transformed radial waveforms (P1TF and AP
calibrated to aortic PP. n  153, 127, and 131 for age groups 40 years, 40 towere 24% (95% CI: 5% to 42%), 10% (95% CI: 0% to 28%),
and 27% (95% CI: 6% to 46%), respectively.
Discussion
In older subjects, CVD events are most closely related to
pPP and, at all ages, the combination of pPP and MAP
provides prediction of CVD events similar to the combina-
tion of systolic and diastolic blood pressures (17). pPP,
unlike mean or diastolic blood pressure, continues to in-
crease with age, and the total age-related increase in pPP is
greater in women compared with men (18). Studies using a
nistration of sublingual nitroglycerin (NTG) (400 g).
after NTG. Abd Ao  abdominal aorta; other abbreviations as in Figure 1.
pectively) and carotid P1 and AP (P1CA and APCA, respectively)
rs, and 50 years, respectively. Abbreviations as in Figure 1.G
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January 31, 2012:475–83 Progression of Central Pulse Pressurevalidated indirect method based on radial tonometry
(SphygmoCor) for estimating cPP suggest cPP predicts
CVD events better than pPP (7,8). Not all studies using
other methods support this finding (19), but the majority
show a strong trend to better prediction of CVD events by
using cPP compared with pPP (20). Because amplification
of pPP over cPP is greater in younger subjects, the prog-
nostic importance of pPP to CVD events in younger
subjects may have been underestimated (21).
To our knowledge, this is the first prospective study to
examine the age-related increase in cPP in women and to
examine its hemodynamic determinants. Over a follow-up
period of 10 years, true MAP obtained by integration did
not change significantly, but pPP and cPP increased mark-
edly, with a mean increase of 10.3 mm Hg for cPP. In
younger women, the absolute increase in cPP was greater
than that in pPP and, at all ages, the percentage change in
cPP was greater than that in pPP. When cPP was parti-
tioned into the sum of its components P1 and AP, we found
that although AP accounted for only a small proportion of
cPP (24% in the entire cohort at baseline), increases in AP
contributed as much or more (in women50 years of age at
baseline) than those of P1 to the widening of cPP over the
follow-up period. The magnitude of the contribution of AP
to progression of cPP is of importance because, in contrast
with P1, AP is independent of the intrinsic stiffness of the
arterial wall as measured by using PWV (12). This finding
was confirmed in the present study using both AP derived
from carotid and transformed radial waveforms. AP has
generally been regarded as a measure of pressure wave
reflection influenced by the tapering of the arterial tree and
hence by arterial tone in muscular arteries (5), although
other factors such as the “reservoir function” of the aorta
have been suggested to contribute to AP (10). AP is known
to be influenced by arterial tone, with nitrovasodilators
being particularly effective in reducing AP (16), an affect
attributed to selective vasodilation of large muscular arteries
reducing pressure wave reflection (15).
To test our finding that widening of PP is due, in large
part, to a increase in AP that is potentially reversible, we
examined the response of cPP and its components to NTG.
Heritability and Environmental Parameter Estimates and Model FitTable 3 Heritability and Environ ental Parameter Estimates an
Parameter Model* A (95% CI) C (95% CI)
 cPP ACE 0.22 (0.00–0.42) 0.02 (0.00–0.29)
AE 0.24 (0.05–0.42) —
 P1 ACE 0.10 (0.00–0.23) 0.00 (0.00–0.21)
AE 0.10 (0.00–0.28) —
 AP ACE 0.27 (0.00–0.46) 0.00 (0.00–0.18)
AE 0.27 (0.06–0.46) —
*All variables were adjusted for baseline age, hypertension treatment at baseline and follow-up,
statistic.
A  additive genetic factors; C  common environment; CI  confidence interval; E  unique e
P1  annual progression in P1;  AP  annual progression in augmentation pressure.This is the first study to evaluate effects of NTG to ndetermine whether a clinically significant age-related in-
crease in cPP can be reversed by reducing AP by using
NTG. NTG (400 g s/l) was able to reduce cPP by almost
0 mm Hg, a change in cPP equivalent to that seen across
decade of aging. The decrease in cPP was entirely
ttributable to a decrease in AP; there was no significant
ffect on P1 or on PWV. The decrease in AP was, however,
ssociated with an increase in arterial diameters with greater
hange in more muscular compared with elastic arteries.
his finding confirms the potential to reverse age-related
idening of PP by interventions that selectively dilate large
rteries and reduce AP. These results also inform the likely
ontributions of wave reflection and reservoir (10) to AP.
he fact that AP is independent of PWV, a major deter-
inant of reservoir, but is influenced by vasodilation of
uscular arteries is more in keeping with a predominant
ffect of pressure wave reflection rather than reservoir on
P. However, an increase in functional compliance or
eservoir could result from a relatively small increase in
ortic diameter.
Our findings further suggest that, in addition to the
elative importance of peripheral amplification of cPP, and
he relative progression of pPP and cPP, the mechanisms
overning progression of cPP differ with age. Although the
ontribution of progression in AP to the age-related wid-
ning of cPP was seen in both younger and older women,
he contribution of AP was particularly marked in younger
omen. The relatively greater contribution of P1 to cPP
idening in older women is consistent with previous obser-
ations of a nonlinear increase in aortic stiffening with age
22,23). Thus, in older subjects, a stiffer aorta may be a
elatively more important determinant of both cPP and
PP, possibly through its effects on incident wave magni-
ude. The reduced progression of AIx with age is explicable
y both P1 and AP increasing and contributing equally to
PP progression (24). The differing age-related changes in
P and P1, the determinants of AIx, make the interpreta-
ion of age-related change in AIx complex.
The twin design of this study allowed us to examine the
eritability of the progression of cPP and its components.
he main finding was that progression of cPP and AP (but
stics for Progression of Central Pulse Pressuredel Fit Statistics for Progression of Central Pulse Pressure
E (95% CI)
Model Fit
–2ll df  Chi-Square p Value
6 (0.58–0.97) 939.914 369 — —
6 (0.58–0.96) 939.920 370 0.005 0.942
0 (0.72–1.00) 754.390 368 — —
0 (0.72–1.00) 754.390 369 0.000 —†
3 (0.54–0.94) 486.417 369 — —
3 (0.54–0.94) 486.417 370 0.000 —†
in mean arterial pressure, and heart rate. †Probability incalculable due to lack of change in fit
ent (incorporating measurement error);  cPP  annual progression in central pulse pressure; Statid Mo
0.7
0.7
0.9
0.9
0.7
0.7
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reported (25) was modest. In particular, the heritability of
AP progression was 27% and low compared with that of
age-specific values of AP, which we and others have
previously estimated to range from 48% to 62% (12,26).
This may be because AP at any age is largely determined by
arterial geometry (and hence is highly heritable [27]),
whereas progression of AP, and particularly that of P1, is
influenced mainly by environmental factors. However, her-
itability is also reduced when random and measurement
error increases, as is likely to be the case with longitudinal
measures.
Study limitations. First, we studied only white female
wins; thus, our findings may not be applicable to men or
on-white women. Characteristics of women in the twins
K cohort are, however, similar to the general UK popu-
ation of women (28). Although twin pairs were randomly
elected, individual subjects were not. However, due to the
elatively large sample size, this selection would be expected
o have a negligible effect on the statistical testing. This
ould make a small difference to the statistical results
btained. Central arterial pressure waveforms at baseline
nd follow-up were estimated from transformed radial
ressure waveforms using a transfer function in the Sphygmo-
or System. Most of the limitations of this technique have
een attributed to identification of P1 (29) and calibration
to brachial blood pressure (30). However, our findings
relating to the contribution of AP to cPP and dissociation
between AP and PWV were confirmed from the carotid
pressure waveform as a close surrogate of aortic pressure
acquired independently of a transfer function. Even if the
identification of P1 was subject to error, the finding that AP
as obtained by the SphygmoCor System is unrelated to
PWV, can be changed independently of PWV, and is a
major contributor to the age-related widening of cPP
supports the conclusion that a major component of the
age-related increase in cPP is independent of PWV irre-
spective of the exact definition of P1 and/or AP.
Conclusions
The widening of cPP with age in women is driven in large
part by an increase in AP unrelated to aortic stiffness. It can
be reversed by NTG, which dilates large arteries and lowers
AP with no significant effect on P1, the component of the
pressure pulse related to aortic stiffness. Interventions such
as NTG that act to reduce AP should be explored for the
treatment of systolic and isolated systolic hypertension.
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